98977-34-5

Basic information

• Product Name: N-Boc-3-carboethoxy-4-piperidone
• Synonyms: Ethyl N-Boc-4-oxopiperidine-3-carboxylate;N-Boc-3-carboethoxy piperidone;Ethyl 1-tert-Butoxycarbonyl-4-oxo-3-piperidinecarboxylate;N-Boc-3-Carboethxy-4-Piperidone;1,3-Piperidinedicarboxylic acid, 4-oxo-, 1-(1,1-diMethylethyl) 3-ethyl ester;1-Tert-butoxycarbonyl-4-oxo-3-piperidinecarboxylate ethyl ester/N-Boc-3-carboethoxy-4-piperidone;1-tert-Butoxycarbonyl-3-(ethoxycarbonyl)piperidin-4-one;Ethyl 1-tert-Butoxycarbonyl-4-oxo-3-piperidinecarboxylate
• CAS NO: 98977-34-5
• Molecular Formula: C₁₃H₂₁NO₅
• Molecular Weight: 271.31
• Product Categories: pharmacetical;API intermediates
• Mol File: 98977-34-5.mol
• Article Data: 2

Chemical Properties

• Melting Point: 62.0 to 66.0 °C
• Boiling Point: 364.593 °C at 760 mmHg
• Flash Point: 174.3 °C
• Appearance: /
• Density: 1.153 g/cm³
• Vapor Pressure: 1.66E-05mmHg at 25°C
• Refractive Index: 1.482
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 11.08±0.20(Predicted)
• CAS DataBase Reference: N-Boc-3-carboethoxy-4-piperidone(CAS DataBase Reference)
• NIST Chemistry Reference: N-Boc-3-carboethoxy-4-piperidone(98977-34-5)
• EPA Substance Registry System: N-Boc-3-carboethoxy-4-piperidone(98977-34-5)

Safety Data

• Statements: 36/38
• Safety Statements: 36
• Hazardous Substances Data: 98977-34-5(Hazardous Substances Data)

Usage

General Description

N-Boc-3-carboethoxy-4-piperidone, also known as Boc-piperidone, is a chemical compound with the molecular formula C13H21NO4. It is a white to off-white crystalline powder that is commonly used as a building block in organic synthesis, particularly in the pharmaceutical industry. It is typically used as a key intermediate in the production of various drugs and pharmaceutical products. N-Boc-3-carboethoxy-4-piperidone is known for its potential to act as a precursor in the synthesis of a variety of bioactive molecules. Its versatile nature and reactivity make it an important tool for chemists in the development of new drug candidates and therapeutic agents.

InChI:InChI=1/C13H21NO5/c1-5-18-11(16)9-8-14(7-6-10(9)15)12(17)19-13(2,3)4/h9H,5-8H2,1-4H3

Upstream product

• 41276-30-6 C₉H₁₄O₃NC₆H₅ 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 152559-30-3 5-tert-butoxycarbonyl-3-oxo-2,3,4,5,6,7-hexahydropyrazolo<4,3-c>pyridine 
• 532977-39-2 4-((R)-1-phenylethylamino)-5,6-dihydro-2H-pyridine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester 
• 947403-75-0 4-amino-5,6-dihydro-2H-pyridine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester 
• 388109-78-2 1-(tert-butyl) 3-ethyl (3S,4R)-4-(((R)-1-phenylethyl)amino)piperidine-1,3-dicarboxylate 
• 388108-48-3 (3R,4R)-4-amino-3-[(S)-3-(4-fluoro-benzyl)-piperidine-1-carbonyl]-piperidine-1-carboxylic acid t-butyl ester 
• 388108-84-7 (3R,4R)-4-amino-3-[(S)-3-(4-fluoro-benzyl)-piperidin-1-ylmethyl]-piperidine-1-carboxylic acid t-butyl ester 
• 388097-48-1 (3R,4R)-4-[3-(5-acetyl-4-methyl-thiazol-2-yl)-ureido]-3-[(S)-3-(4-fluoro-benzyl)-piperidin-1-ylmethyl]-piperidine-1-carboxylic acid t-butyl ester 
• 532977-52-9 (3R,4R)-1-(tert-butoxycarbonyl)-4-((R)-1-phenylethylamino)piperidine-3-carboxylic acid 
• 388108-32-5 (3R,4R)-4-((R)-1-phenylethylamino)piperidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester 
• 455954-82-2 4-(4-chloro-phenyl)-piperidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester 
• 455954-87-7 4-(4-fluoro-phenyl)-piperidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester 

Relevant articles and documents

PYRIMIDINE-BASED BICYCLES AS ANTIVIRAL AGENTS FOR THE TREATMENT AND PREVENTION OF HIV INFECTION

This invention relates to pyrimidine derivatives, having HIV replication inhibiting. The present invention provides new pyrimidine compounds, designed for the treatment and prevention of HIV-mediated diseases. The invention further relates to pharmaceutical compositions and drugs contained in them. The invention also relates to the use of abovementioned compounds for the treatment and/or prevention of HIV in subjects with HIV-infection (human immunodeficiency virus) or having risk of getting HIV-infection.